List of Excipients in API EVEROLIMUS
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing EVEROLIMUS
Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
---|---|---|---|---|---|
Novartis Pharmaceuticals Corporation | ZORTRESS | everolimus | 0078-0417 | ANHYDROUS LACTOSE | |
Novartis Pharmaceuticals Corporation | ZORTRESS | everolimus | 0078-0417 | BUTYLATED HYDROXYTOLUENE | |
Novartis Pharmaceuticals Corporation | ZORTRESS | everolimus | 0078-0417 | CROSPOVIDONE | |
Novartis Pharmaceuticals Corporation | ZORTRESS | everolimus | 0078-0417 | HYPROMELLOSES | |
>Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing EVEROLIMUS
Company | Ingredient | NDC | Excipient |
---|---|---|---|
Hikma Pharmaceuticals USA Inc | everolimus | 0054-0470 | ANHYDROUS LACTOSE |
Hikma Pharmaceuticals USA Inc | everolimus | 0054-0470 | BUTYLATED HYDROXYTOLUENE |
Hikma Pharmaceuticals USA Inc | everolimus | 0054-0470 | CROSPOVIDONE |
Hikma Pharmaceuticals USA Inc | everolimus | 0054-0470 | HYPROMELLOSE 2910 |
>Company | >Ingredient | >NDC | >Excipient |
Detailed excipient profiles for EVEROLIMUS
Excipient focus: ACETONE
EVEROLIMUS drug variants containing ACETONE
Company | Ingredient | NDC |
---|---|---|
Breckenridge Pharmaceutical Inc | everolimus | 51991-821 |
Natco Pharma Limited | everolimus | 63850-0058 |
>Company | >Ingredient | >NDC |
EVEROLIMUS drug variants not containing ACETONE
Company | Ingredient | NDC |
---|---|---|
Hikma Pharmaceuticals USA Inc | everolimus | 0054-0470 |
Hikma Pharmaceuticals USA Inc | everolimus | 0054-0480 |
Hikma Pharmaceuticals USA Inc | everolimus | 0054-0604 |
Novartis Pharmaceuticals Corporation | everolimus | 0078-0417 |
>Company | >Ingredient | >NDC |
Excipient focus: ANHYDROUS LACTOSE
EVEROLIMUS drug variants containing ANHYDROUS LACTOSE
Company | Ingredient | NDC |
---|---|---|
Hikma Pharmaceuticals USA Inc | everolimus | 0054-0470 |
Hikma Pharmaceuticals USA Inc | everolimus | 0054-0480 |
Hikma Pharmaceuticals USA Inc | everolimus | 0054-0604 |
Novartis Pharmaceuticals Corporation | everolimus | 0078-0417 |
>Company | >Ingredient | >NDC |
EVEROLIMUS drug variants not containing ANHYDROUS LACTOSE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: BUTYLATED HYDROXYTOLUENE
EVEROLIMUS drug variants containing BUTYLATED HYDROXYTOLUENE
Company | Ingredient | NDC |
---|---|---|
Hikma Pharmaceuticals USA Inc | everolimus | 0054-0470 |
Hikma Pharmaceuticals USA Inc | everolimus | 0054-0480 |
Hikma Pharmaceuticals USA Inc | everolimus | 0054-0604 |
Novartis Pharmaceuticals Corporation | everolimus | 0078-0417 |
>Company | >Ingredient | >NDC |
EVEROLIMUS drug variants not containing BUTYLATED HYDROXYTOLUENE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: CROSCARMELLOSE SODIUM
EVEROLIMUS drug variants containing CROSCARMELLOSE SODIUM
Company | Ingredient | NDC |
---|---|---|
Mylan Pharmaceuticals Inc | everolimus | 0378-0005 |
Mylan Pharmaceuticals Inc | everolimus | 0378-3096 |
>Company | >Ingredient | >NDC |
EVEROLIMUS drug variants not containing CROSCARMELLOSE SODIUM
Company | Ingredient | NDC |
---|---|---|
Hikma Pharmaceuticals USA Inc | everolimus | 0054-0470 |
Hikma Pharmaceuticals USA Inc | everolimus | 0054-0480 |
Hikma Pharmaceuticals USA Inc | everolimus | 0054-0604 |
Novartis Pharmaceuticals Corporation | everolimus | 0078-0417 |
>Company | >Ingredient | >NDC |
Excipient focus: CROSPOVIDONE
EVEROLIMUS drug variants containing CROSPOVIDONE
Company | Ingredient | NDC |
---|---|---|
Hikma Pharmaceuticals USA Inc | everolimus | 0054-0470 |
Hikma Pharmaceuticals USA Inc | everolimus | 0054-0480 |
Hikma Pharmaceuticals USA Inc | everolimus | 0054-0604 |
Novartis Pharmaceuticals Corporation | everolimus | 0078-0417 |
>Company | >Ingredient | >NDC |
EVEROLIMUS drug variants not containing CROSPOVIDONE
Company | Ingredient | NDC |
---|---|---|
Mylan Pharmaceuticals Inc | everolimus | 0378-3096 |
>Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE
EVEROLIMUS drug variants containing HYPROMELLOSE
Company | Ingredient | NDC |
---|---|---|
Breckenridge Pharmaceutical Inc | everolimus tablets | 51991-379 |
>Company | >Ingredient | >NDC |
EVEROLIMUS drug variants not containing HYPROMELLOSE
Company | Ingredient | NDC |
---|---|---|
Hikma Pharmaceuticals USA Inc | everolimus | 0054-0470 |
Hikma Pharmaceuticals USA Inc | everolimus | 0054-0480 |
Hikma Pharmaceuticals USA Inc | everolimus | 0054-0604 |
Novartis Pharmaceuticals Corporation | everolimus | 0078-0417 |
>Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE 2208
EVEROLIMUS drug variants containing HYPROMELLOSE 2208
Company | Ingredient | NDC |
---|---|---|
Upsher-Smith Laboratories LLC | everolimus | 0245-0822 |
Biocon Pharma Inc | everolimus | 70377-010 |
>Company | >Ingredient | >NDC |
EVEROLIMUS drug variants not containing HYPROMELLOSE 2208
Company | Ingredient | NDC |
---|---|---|
Hikma Pharmaceuticals USA Inc | everolimus | 0054-0470 |
Hikma Pharmaceuticals USA Inc | everolimus | 0054-0480 |
Hikma Pharmaceuticals USA Inc | everolimus | 0054-0604 |
Novartis Pharmaceuticals Corporation | everolimus | 0078-0417 |
>Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE 2910
EVEROLIMUS drug variants containing HYPROMELLOSE 2910
Company | Ingredient | NDC |
---|---|---|
Hikma Pharmaceuticals USA Inc | everolimus | 0054-0470 |
Hikma Pharmaceuticals USA Inc | everolimus | 0054-0480 |
Hikma Pharmaceuticals USA Inc | everolimus | 0054-0604 |
Teva Pharmaceuticals USA Inc | everolimus | 0093-7766 |
>Company | >Ingredient | >NDC |
EVEROLIMUS drug variants not containing HYPROMELLOSE 2910
Company | Ingredient | NDC |
---|---|---|
Novartis Pharmaceuticals Corporation | everolimus | 0078-0417 |
Novartis Pharmaceuticals Corporation | everolimus | 0078-0566 |
Upsher-Smith Laboratories LLC | everolimus | 0245-0822 |
Natco Pharma Limited | everolimus | 63850-0062 |
>Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSES
EVEROLIMUS drug variants containing HYPROMELLOSES
Company | Ingredient | NDC |
---|---|---|
Novartis Pharmaceuticals Corporation | everolimus | 0078-0417 |
Novartis Pharmaceuticals Corporation | everolimus | 0078-0566 |
Natco Pharma Limited | everolimus | 63850-0062 |
Ascend Laboratories LLC | everolimus | 67877-718 |
>Company | >Ingredient | >NDC |
EVEROLIMUS drug variants not containing HYPROMELLOSES
Company | Ingredient | NDC |
---|---|---|
Hikma Pharmaceuticals USA Inc | everolimus | 0054-0470 |
Hikma Pharmaceuticals USA Inc | everolimus | 0054-0480 |
Hikma Pharmaceuticals USA Inc | everolimus | 0054-0604 |
Teva Pharmaceuticals USA Inc | everolimus | 0093-7766 |
>Company | >Ingredient | >NDC |
Excipient focus: LACTOSE MONOHYDRATE
EVEROLIMUS drug variants containing LACTOSE MONOHYDRATE
Company | Ingredient | NDC |
---|---|---|
Novartis Pharmaceuticals Corporation | everolimus | 0078-0417 |
Novartis Pharmaceuticals Corporation | everolimus | 0078-0566 |
Teva Pharmaceuticals USA Inc | everolimus | 0093-7766 |
Upsher-Smith Laboratories LLC | everolimus | 0245-0822 |
>Company | >Ingredient | >NDC |
EVEROLIMUS drug variants not containing LACTOSE MONOHYDRATE
Company | Ingredient | NDC |
---|---|---|
Hikma Pharmaceuticals USA Inc | everolimus | 0054-0470 |
Hikma Pharmaceuticals USA Inc | everolimus | 0054-0480 |
Hikma Pharmaceuticals USA Inc | everolimus | 0054-0604 |
Mylan Pharmaceuticals Inc | everolimus | 0378-3096 |
>Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
EVEROLIMUS drug variants containing MAGNESIUM STEARATE
Company | Ingredient | NDC |
---|---|---|
Hikma Pharmaceuticals USA Inc | everolimus | 0054-0470 |
Hikma Pharmaceuticals USA Inc | everolimus | 0054-0480 |
Hikma Pharmaceuticals USA Inc | everolimus | 0054-0604 |
Novartis Pharmaceuticals Corporation | everolimus | 0078-0417 |
>Company | >Ingredient | >NDC |
EVEROLIMUS drug variants not containing MAGNESIUM STEARATE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: MANNITOL
EVEROLIMUS drug variants containing MANNITOL
Company | Ingredient | NDC |
---|---|---|
Mylan Pharmaceuticals Inc | everolimus | 0378-0005 |
>Company | >Ingredient | >NDC |
EVEROLIMUS drug variants not containing MANNITOL
Company | Ingredient | NDC |
---|---|---|
Hikma Pharmaceuticals USA Inc | everolimus | 0054-0470 |
Hikma Pharmaceuticals USA Inc | everolimus | 0054-0480 |
Hikma Pharmaceuticals USA Inc | everolimus | 0054-0604 |
Novartis Pharmaceuticals Corporation | everolimus | 0078-0417 |
>Company | >Ingredient | >NDC |
Excipient focus: MICROCRYSTALLINE CELLULOSE 102
EVEROLIMUS drug variants containing MICROCRYSTALLINE CELLULOSE 102
Company | Ingredient | NDC |
---|---|---|
Mylan Pharmaceuticals Inc | everolimus | 0378-0005 |
>Company | >Ingredient | >NDC |
EVEROLIMUS drug variants not containing MICROCRYSTALLINE CELLULOSE 102
Company | Ingredient | NDC |
---|---|---|
Hikma Pharmaceuticals USA Inc | everolimus | 0054-0470 |
Hikma Pharmaceuticals USA Inc | everolimus | 0054-0480 |
Hikma Pharmaceuticals USA Inc | everolimus | 0054-0604 |
Novartis Pharmaceuticals Corporation | everolimus | 0078-0417 |
>Company | >Ingredient | >NDC |
Excipient focus: SILICON DIOXIDE
EVEROLIMUS drug variants containing SILICON DIOXIDE
Company | Ingredient | NDC |
---|---|---|
Mylan Pharmaceuticals Inc | everolimus | 0378-0005 |
Mylan Pharmaceuticals Inc | everolimus | 0378-3096 |
Par Pharmaceutical Inc | everolimus | 49884-119 |
>Company | >Ingredient | >NDC |
EVEROLIMUS drug variants not containing SILICON DIOXIDE
Company | Ingredient | NDC |
---|---|---|
Hikma Pharmaceuticals USA Inc | everolimus | 0054-0470 |
Hikma Pharmaceuticals USA Inc | everolimus | 0054-0480 |
Hikma Pharmaceuticals USA Inc | everolimus | 0054-0604 |
Novartis Pharmaceuticals Corporation | everolimus | 0078-0417 |
>Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.